These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27211205)

  • 41. Evaluation of patients for secondary hypertension.
    Weinberger MH; Grim CE; Donohue JP
    Trans Am Assoc Genitourin Surg; 1979; 71():93-5. PubMed ID: 397653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile.
    Shibata H; Suzuki H; Murakami M; Sato A; Saruta T
    J Hypertens; 1994 Nov; 12(11):1275-84. PubMed ID: 7868875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.
    Myint KS; Watts M; Appleton DS; Lomas DJ; Jamieson N; Taylor KP; Coghill S; Brown MJ
    J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):103-6. PubMed ID: 18584586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.
    Jansen PM; van den Born BJ; Frenkel WJ; de Bruijne EL; Deinum J; Kerstens MN; Smulders YM; Woittiez AJ; Wijbenga JA; Zietse R; Danser AH; van den Meiracker AH
    J Hypertens; 2014 Jan; 32(1):115-26. PubMed ID: 24018605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity.
    Lim PO; Jung RT; MacDonald TM
    J Hum Hypertens; 2002 Mar; 16(3):153-8. PubMed ID: 11896503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Is the aldosterone-renin ratio useful in screening for primary aldosteronism?].
    Kreze A; Okálová D; Hrnclar J
    Vnitr Lek; 1996 Sep; 42(9):649-51. PubMed ID: 8984776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary hyperaldosteronism in a patient with end-stage renal disease.
    Kazory A; Weiner ID
    Nephrol Dial Transplant; 2007 Mar; 22(3):917-9. PubMed ID: 17127694
    [No Abstract]   [Full Text] [Related]  

  • 48. [Primary hyperaldosteronism in hypertension].
    Girerd X
    Rev Med Suisse; 2008 Sep; 4(170):1924-6. PubMed ID: 18847121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary aldosteronism: A common and curable form of hypertension.
    Young WF
    Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea-what do we know so far?
    Loh HH; Sukor N
    J Hum Hypertens; 2020 Jan; 34(1):5-15. PubMed ID: 31822780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Misleading diagnosis of renal artery stenosis by magnetic resonance angiography in a patient with primary aldosteronism.
    Ippersiel V; Rosière A; Michel L; Donckier J
    Acta Chir Belg; 2012; 112(4):302-6. PubMed ID: 23008996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism].
    Ríos MC; Izquierdo A; Sotelo M; Honnorat E; Rodríguez Cuimbra S; Catay E; Popescu BM
    Medicina (B Aires); 2011; 71(6):525-30. PubMed ID: 22167725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary aldosteronism. Part I. Diagnosis of primary hyperaldosteronism.
    Vallotton MB
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):47-52. PubMed ID: 8796138
    [No Abstract]   [Full Text] [Related]  

  • 54. [Diazoxide test in the diagnosis of arterial hypertension: modifications in the levels of renin and aldosterone in blood of patients with various restrains of the renal function].
    Cecchettin M; Albertini A; Ghielmi S; Signorini C; Orlandini A; Maiorca R
    Quad Sclavo Diagn; 1975 Jun; 11(2):397-406. PubMed ID: 1223945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Primary hyperaldosteronism: a diagnostic algorithm].
    Del Giudice A; Prencipe M; Aucella F
    G Ital Nefrol; 2013; 30(3):. PubMed ID: 23832473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea.
    Linz D; Mahfoud F; Linz B; Hohl M; Schirmer SH; Wirth KJ; Böhm M
    Am J Hypertens; 2014 Oct; 27(10):1293-300. PubMed ID: 24622919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [New concepts in searching for primary aldosteronism in hypertension: advances in screening, confirming and subtyping tests].
    Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):865-7. PubMed ID: 17217707
    [No Abstract]   [Full Text] [Related]  

  • 59. Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.
    Shibata H; Itoh H
    Am J Hypertens; 2012 May; 25(5):514-23. PubMed ID: 22258336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for surgically correctable hypertension caused by primary aldosteronism.
    Carey RM
    Arch Intern Med; 1981 Nov; 141(12):1594. PubMed ID: 7030246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.